To Top

Content Filter


1933 Articles available
Drug Development

Novartis Kisqali® now first and only CDK4/6 inhibitor indicated in US

PR-M07-18-NI-068
Clinical Trials

Allergan and Molecular Partners Announce Two Positive Phase 3 Clinical Trials

PR-M07-18-NI-067
Research

Researchers Are One Step Closer to Developing Eye Drops to Treat Age-related Macular Degeneration (AMD)

PR-M07-18-NI-066
Announcement

Bryan Zerhusen, Ph.D. Joins Cantor Colburn to Chair its Life Sciences Practice Group

PR-M07-18-NI-072
Opioids

HBI Solutions' Tool Predicts Who Is Likely to Abuse Opioids Using Medical and Social Data

PR-M07-18-NI-064
Collaboration

Vyriad Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer

PR-M07-18-NI-065
Phase 3

PainReform Gets FDA Approval for Phase III Post-Operative Pain Relief Study

PR-M07-18-NI-062
Drug Development

Appeals Board Rules in Favor of Novartis and its Multiple Sclerosis Drug Gilenya

PAO-M07-18-NI-014
FDA

Safety Concerns Raised about Valsartan from China

PAO-M07-18-NI-013
FDA Approval

Xtandi Gets FDA Second Cancer Therapy Approval

PAO-M07-18-NI-012
Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

PAO-M07-18-NI-011
Clinical Data

Pulmatrix Announces Positive Top-Line Preliminary Results from Part 3 of the 3-Part Phase 1/1b Clinical Trial of Pulmazole

PR-M07-18-NI-058
Research

IDTechEx Research: Long Term In Vivo Performance of Tissue Engineered Heart Valves

PR-M07-18-NI-057
Market Prediction

Biosurgery Market Worth 15.58 Billion USD by 2023

PR-M07-18-NI-059
Opiods

Braeburn Announces PDUFA Date for CAM2038 for the Treatment of Opioid Use Disorder

PR-M07-18-NI-055
FDA

FDA Committee Gives Nod to New Treatment for Plasmodium Vivax Malaria

PAO-M07-18-NI-010
Drug Development

New Antibiotic to be Tested against Potential Bioweapons

PAO-M07-18-NI-009
Announcement

Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product

PR-M07-18-NI-053
Preferred Provider

Leiters and Avanos Medical Announce Preferred Provider Agreement

PR-M07-18-NI-054
Drug Development

Upsher-Smith Launches Vigabatrin For Oral Solution Under The Brand Name Vigadrone™

PR-M07-18-NI-051
Acquisition

AMPAC Fine Chemicals To Be Acquired By SK Holdings

PR-M07-18-NI-050
FDA Approval

FDA approves the first drug with an indication for treatment of smallpox

PR-M07-18-NI-046
FDA Approval

U.S. FDA Approves XTANDI® (enzalutamide) for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)

PR-M07-18-NI-047
Antibiotic Resistance

Roche PCT assay cleared for expanded use - Important tool in antibiotic resistance crisis

PR-M07-18-NI-049
Market Prediction

Aseptic Sampling Market Worth 1,247.0 Million USD by 2023

PR-M07-18-NI-050
Announcement

Bausch Health Companies Inc. Completes Name Change

PR-M07-18-NI-048
Advertising

Digital Ad Spending by Pharma is Growing Slowly

PAO-M07-18-NI-008
FDA Approval

New Treatment for Excessive Sweating Gets FDA Approval

PAO-M07-18-NI-008
Investment

Women’s Health Company to Expand

PAO-M07-18-NI-007
FDA Approval

Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves

PR-M07-18-NI-045
Announcement

Natera Announces Pricing of Follow-On Offering

PR-M07-18-NI-044
New Drug Application

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax

PR-M07-18-NI-041
Clinical Trials

CStone's PD-1 inhibitor CS1003 receives clinical trial approval in China

PR-M07-18-NI-042
Clinical Research

Eating Well Might Improve Cancer Treatments

PAO-M07-18-NI-006
Investment

Organ-on-a-Chip Company Raises $36 Million

PAO-M07-18-NI-005
Acquisition

Otsuka Pharmaceutical to Acquire Visterra

PR-M07-18-NI-040
Drug Development

SCYNEXIS Reports Positive Results from Phase 2b Dose-Finding Study of Oral SCY-078 in Vulvovaginal Candidiasis

PR-M07-18-NI-039
Announcement

BioCryst Provides Update on Strategy, Pipeline and Outlook

PR-M07-18-NI-037
Cell and Gene Therapy

MedImmune and 4D Molecular Therapeutics Collaborate to Design, Develop and Commercialize AAV Gene Therapy for Chronic Lung Disease

PR-M07-18-NI-038
Pricing

Pfizer Announces it Will Defer Company’s Price Increases

PR-M07-18-NI-036
Acquisition

Medline Announces Acquisition of NeuroGym Technologies

PR-M07-18-NI-035
FDA Clearance

RedDress Receives FDA 510(k) Clearance for RD1 System

PR-M07-18-NI-032
Collaboration

Applied BioMath, LLC Announces Collaboration with Revitope for Mechanistic PK/PD Modeling in Solid Tumors

PR-M07-18-NI-034
Acquisition

EnsembleIQ Acquires Media Brands from Lebhar-Friedman

PR-M07-18-NI-031
Clinical Study

BioArctic Receives Regulatory Approval in Finland for a Clinical Study in Patients With Complete Spinal Cord Injury

PR-M07-18-NI-033
Announcement

Bosch Packaging Business Up for Sale

PAO-M07-18-NI-004
Opioids

Gottlieb Discusses Results of Online Opioid Summit

PAO-M07-18-NI-003
Announcement

Alcon Set Out On its Own

PAO-M07-18-NI-002
Approvals

Japan Approves Two New AstraZeneca Cancer Meds

PAO-M07-18-NI-001
Acquisition

BD Acquires TVA Medical to Advance Leadership in Solutions for Chronic Kidney Disease

PR-M07-18-NI-030
FDA Filing Acceptance

Bausch + Lomb Announces U.S. FDA Filing Acceptance For Loteprednol Etabonate Ophthalmic Gel, 0.38%

PR-M07-18-NI-029
Drug Development

Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon® Patch

PR-M07-18-NI-028
FDA Clearance

Companion Medical Announces FDA Clearance for the InPen System for Android

PR-M07-18-NI-026
Announcement

Governor Murphy Announces Teva Pharmaceuticals to Locate US Headquarters in New Jersey

PR-M07-18-NI-025
Packaging

Bosch Plans to Sell its Packaging Business

PR-M07-18-NI-024
Investment

Evonetix Awarded Innovate UK Funding for £1.3 Million Gene Synthesis Project

PR-M07-18-NI-023
Serialization

Recipharm Announces Global Serialisation Collaboration

PR-M07-18-NI-022
Investment

Biogen Exercises Option to Increase Ownership in Samsung Bioepis

PR-M07-18-NI-018
Bioconjugation

Abzena and Telix sign strategic manufacturing and bioconjugation agreement

PR-M07-18-NI-016
Cannabis

The Wave of Cannabis Legalization is Impending Abroad

PR-M07-18-NI-019
Life Sciences

Google, Amazon, Facebook and Apple Propel the Life Sciences Industry with Strategic Partnerships

PR-M07-18-NI-020
Acquisition

Catalent Signs Agreement to Acquire Juniper Pharmaceuticals, Inc.

PR-M07-18-NI-011
Acquisition

Amazon to Acquire PillPack

PR-M07-18-NI-014
Announcement

Adamis Pharmaceuticals Announces Distribution and Commercialization Agreement for Symjepi

PR-M07-18-NI-011
Precision Medicine

BC Platforms and Tieto Partner to Integrate Genomic and Clinical Data to Advance Precision Medicine

PR-M07-18-NI-012
FDA Approval

Dermira Receives FDA Approval for Qbrexza™ (glycopyrronium) Cloth to Treat Primary Axillary Hyperhidrosis

PR-M07-18-NI-013
Biosimulation

The global biosimulation market size is expected to reach USD 3.77 billion by 2024

PR-M07-18-NI-010
Investment

I-Mab Successfully Raised USD 220 Million in Series C Funding

PR-M07-18-NI-008
FDA

FDA approves novel device for treating breathing difficulty from severe emphysema

PR-M07-18-NI-008
Announcement

ChinaRx Author, Rosemary Gibson, to Speak at Rx-360 Conference

PR-M07-18-NI-003
Market Intelligence

Microbiology Testing Market to Grow at 6.4% CAGR to 2023

PR-M07-18-NI-002
Acquisition

Bain Capital Private Equity Acquires DSM Sinochem Pharmaceuticals

PR-M07-18-NI-001
Announcement

Science Exchange Adds Allergan EVP & Chief R&D Officer David Nicholson to Its Board of Directors

PR-M06-18-NI-099
Investment

Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement

PR-M06-18-NI-098
Clinical Data

Novartis and Amgen Highlight Findings from a Large Global Patient Survey on Migranes

PR-M06-18-NI-101
Biosimilars

Amgen Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Candidate To Infliximab

PR-M06-18-NI-100
Orphan Drug

Arrowhead Receives Positive EMA Opinion on Orphan Designation for ARO-AAT for Treatment of Congenital Alpha-1 Antitrypsin Deficiency

PR-M06-18-NI-097
Innovation

Distek, Inc. Releases the PrepEngine Mini Sample Prep Station

PR-M06-18-NI-096
Announcement

GE Healthcare to Become Standalone Company

PR-M06-18-NI-095
Genome

Precision BioSciences Raises $110M to Advance ARCUS Genome Editing Programs

PR-M06-18-NI-093
Strategic Collaboration

AbbVie and Calico Announce Extension of Groundbreaking Collaboration

PR-M06-18-NI-092
Bioprinting

3D Bioprinting Market Size Worth $2.6 Billion by 2024 | CAGR 18.4%: Grand View Research, Inc.

PR-M06-18-NI-090
Clinical Trials

Javara Launches Next Generation Integrated Clinical Trials Platform

PR-M06-18-NI-088
Clinical Trials

Rigel Initiates Phase 1 Clinical Trial of R835, an IRAK1/4 Inhibitor for Autoimmune and Inflammatory Diseases

PR-M06-18-NI-091
Clinical Trials

Arcus Biosciences and Infinity Pharmaceuticals Announce Clinical Collaboration to Evaluate Lead Programs in Triple-Combination Studies

Drug Delivery

Automated Insulin Delivery System Approved for Use by More Pediatric Patients

PAO-M06-18-NI-023
Immunotherapy

India Gets First Immunotherapy for Lung Cancer

PAO-M06-18-NI-022
Microbiome

Kaleido Raises More Money for Development of Microbiome-Based Therapeutics

PAO-M06-18-NI-021
Insulin

Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes

PR-M06-18-NI-084
Clinical Data

Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In

PR-M06-18-NI-086
Clinical Trials

Oramed Enrolls First Patient in Its Glucose Clamp Study for Oral Insulin

PR-M06-18-NI-083
Research

BNBuilders Completes Construction on Vertex Pharmaceuticals Research Center in San Diego

PR-M06-18-NI-082
Parenterals

A Risk Analysis Approach to Producing Environmentally Sensitive Parenterals

PA0-M06-18-CL-007
Scientific Advisory Council

Mallinckrodt Launches Scientific Advisory Council

PR-M06-18-NI-081
Drug Candidate

Prometic Presents New Data on NASH Drug Candidate PBI-4547

PR-M06-18-NI-080
Orphan Drug

Processa Pharmaceuticals Receives Orphan Designation Status For PCS499 In Necrobiosis Lipoidica From The Food And Drug Administration (FDA)

PR-M06-18-NI-079
Acquisition

Lilly Completes Acquisition of ARMO BioSciences

PR-M06-18-NI-078
Announcement

West Appoints Bernard Birkett to Chief Financial Officer

PR-M06-18-NI-077
Acquisition

Sanofi completes its acquisition of Ablynx following the expiration of the Squeeze-out Procedure

PR-M06-18-NI-074
Capsules

Oramed Initiates Food Effect Study for Its Oral Insulin Capsule ORMD-0801

PR-M06-18-NI-076
Genome

Johnson & Johnson Innovation Opens JLABS @ NYC in Collaboration with New York State and the New York Genome Center

PR-M06-18-NI-075
Capsules

Building Healthcare Brands through Recognizable Capsules

PAO-06-18-CL-004
Antiviral

Progress on New Antiviral Drugs at Chimerix

PAO-M06-18-NI-019
Investment

Successful IPO for Verrica Pharmaceuticals

PAO-M06-18-NI-018
CAR-T Therapy

Cellectic CAR-T Therapy Contains Safety Switch and More

PAO-M06-18-NI-017
CRISPR

New Diagnostic Tool for Heart Disease Based on CRISPR Technology

PAO-M06-18-NI-016
Announcement

NuMedii Expands Board of Directors and Scientific Advisory Board with the Addition of Two Oncology Experts

PR-M06-18-NI-071
Clinical Trials

Aminex Therapeutics Initiates First Clinical Trial of Novel Immunotherapy AMXT 1501 + DFMO in Cancer Patients

PR-M06-18-NI-072
Serialization

Vantage Solutions guides Reed-Lane through smooth serialization projects

PR-M06-18-NI-070
Robotics

Pharmaceutical Robots Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

PR-M06-18-NI-069
Product Launch

Distek, Inc. Releases Small Volume Conversion Kit for symphony 7100 Bathless Dissolution Tester

PR-M06-18-NI-067
Regulatory

Reducing Time to Market with Targeted Regulatory Affairs Support

PAO-06-18-CL-003
Research

A Key to the Cage: Opening the Living Membrane Gate

PR-M06-18-NI-066
Preclinical Data

Artemis Therapeutics Announces Two Recent Publications Highlighting Artemisone's Activity Against Human Cytomegalovirus And Malaria

PR-M06-18-NI-063
FDA Approval

Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays

PR-M06-18-NI-064
Drug Discovery

Could a Bispecific Antibody Be A Functional Cure for AIDS?

PAO-M06-18-NI-015